文献速递乳房整形与再造美容整形

乳房假体隆胸后保留皮肤或乳头乳房切除即刻假体再造并发症的系统综述与荟萃分析

Systematic Review and Meta-Analysis of Complications Following Mastectomy and Prosthetic Reconstruction in Patients With and Without Prior Breast Augmentation.
PubMed 文献 · Aesthet Surg J · 2021-01-01

该系统综述与荟萃分析纳入6项研究,比较有既往隆胸史(241侧乳房)与无隆胸史(1441侧乳房)行保留皮肤或乳头乳房切除即刻假体再造的术后并发症。结果显示两组早期、晚期及总体并发症无显著差异,但隆胸组血肿形成率显著更高,其他并发症无差异。

要点

  • 既往隆胸不显著增加保留皮肤或乳头乳房切除即刻假体再造的总体并发症。
  • 隆胸组血肿形成率显著更高(3.39% vs 2.15%,OR 2.68,95%CI 1.00-7.16,P=0.05)。
  • 血清肿、感染、皮瓣坏死及假体丢失率两组无显著差异。

核心结论

  • 既往隆胸不显著增加保留皮肤或乳头乳房切除即刻假体再造的总体术后并发症。
  • 隆胸患者血肿形成率显著更高,需进一步研究并在术前讨论。

研究设计与样本

  • 系统综述与荟萃分析,2020年2月检索比较有或无既往隆胸史行保留皮肤或乳头乳房切除即刻假体再造的研究。
  • 纳入6项研究,共241侧有隆胸史乳房与1441侧无隆胸史乳房。

主要发现

  • 早期并发症:36.7% vs 24.8%,OR 1.57,95%CI 0.94-2.64,P=0.09。
  • 晚期并发症:10.1% vs 19.9%,OR 0.53,95%CI 0.06-4.89,P=0.57。
  • 总体并发症:36.5% vs 31.2%,OR 1.23,95%CI 0.76-2.00,P=0.40。
  • 血肿形成率:3.39% vs 2.15%,OR 2.68,95%CI 1.00-7.16,P=0.05。
  • 血清肿、感染、乳房切除皮瓣坏死及假体丢失率两组无显著差异。

临床怎么用

  • 术前应告知有隆胸史患者血肿风险可能升高并充分讨论。
  • 总体并发症风险无显著增加,不应仅因既往隆胸而排除即刻假体再造。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is limited evidence available in the literature with regard to the complication profile of mastectomy and immediate prosthetic reconstruction in augmented patients. OBJECTIVES: The aim of this systematic review and meta-analysis was to compare postoperative complications between women with vs without prior augmentation undergoing skin- or nipple-sparing mastectomy and immediate prosthetic reconstruction. METHODS: A systematic search was conducted in February 2020 for studies comparing women with vs without prior augmentation undergoing skin- or nipple-sparing mastectomy and immediate prosthetic reconstruction with documentation of postoperative complications. Outcomes analyzed included early, late, and overall complications. Pooled odds ratios (ORs) with 95% CIs were obtained through meta-analysis. RESULTS: Our meta-analysis, which included 6 studies comparing 241 breasts with prior augmentation and 1441 without, demonstrated no significant difference between the 2 groups in rates of early (36.7% vs 24.8%: OR, 1.57; 95% CI, 0.94-2.64; P = 0.09), late (10.1% vs 19.9%: OR, 0.53; 95% CI, 0.06-4.89; P = 0.57), and overall complications (36.5% vs 31.2%: OR, 1.23; 95% CI, 0.76-2.00; P = 0.40). Subgroup analysis showed a significantly higher rate of hematoma formation in the augmented group (3.39% vs 2.15%: OR, 2.68; 95% CI, 1.00-7.16; P = 0.05), but no difference in rates of seroma, infection, mastectomy skin flap necrosis, and prosthesis loss. CONCLUSIONS: Our meta-analysis suggests that prior augmentation does not significantly increase overall postoperative complications in women undergoing skin- or nipple-sparing mastectomy and immediate prosthetic reconstruction. However, the significantly higher rate of hematoma formation in augmented patients warrants further investigation and preoperative discussion.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Chicco M, Ahmadi AR, Cheng HT, et al. Systematic Review and Meta-Analysis of Complications Following Mastectomy and Prosthetic Reconstruction in Patients With and Without Prior Breast Augmentation. Aesthet Surg J. 2021. PMID: 33480970. doi:10.1093/asj/sjab028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。